TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
China
Shandong Cancer Hospital and Institute, Jinan, Shandong Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality Age range
1 Year and older
Last updated February 2023